Repligen (RGEN) Capital Expenditures Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Intuitive Surgical | 156.17 Bn | 151.78 Bn | 1.83 Bn |
| 2 | Becton Dickinson | 41.51 Bn | 40.49 Bn | 2.15 Bn |
| 3 | Resmed | 30.43 Bn | 28.77 Bn | 890.98 Mn |
| 4 | West Pharmaceutical Services | 22.78 Bn | 22.26 Bn | 296.40 Mn |
| 5 | Solventum | 13.39 Bn | 13.39 Bn | 1.10 Bn |
| 6 | Cooper Companies | 12.33 Bn | 12.20 Bn | 695.20 Mn |
| 7 | Align Technology | 11.65 Bn | 10.59 Bn | 736.59 Mn |
| 8 | Baxter International | 9.81 Bn | 7.77 Bn | 891.00 Mn |
| 9 | Aptargroup | 7.39 Bn | 7.19 Bn | 351.91 Mn |
| 10 | Repligen | 6.39 Bn | 5.41 Bn | 108.28 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -9.09% |
| Dec 31, 2025 | 37.92% |
| Sep 30, 2025 | -33.75% |
| Jun 30, 2025 | 25.36% |
| Mar 31, 2025 | -26.80% |
| Dec 31, 2024 | 207.96% |
| Sep 30, 2024 | 38.95% |
| Jun 30, 2024 | 61.52% |
| Mar 31, 2024 | -58.09% |
| Dec 31, 2023 | 53.11% |
| Sep 30, 2023 | -25.89% |
| Jun 30, 2023 | -16.57% |
| Mar 31, 2023 | -9.99% |
| Dec 31, 2022 | 115.55% |
| Sep 30, 2022 | -119.98% |
| Jun 30, 2022 | 106.26% |
| Mar 31, 2022 | -4.53% |
| Dec 31, 2021 | 136.72% |
| Sep 30, 2021 | -18.18% |
| Jun 30, 2021 | -49.75% |
| Mar 31, 2021 | 77.45% |
| Dec 31, 2020 | -70.78% |
| Sep 30, 2020 | 64.03% |
| Jun 30, 2020 | 46.75% |
| Mar 31, 2020 | 26.53% |
| Dec 31, 2019 | -62.33% |
| Sep 30, 2019 | -4.98% |
| Jun 30, 2019 | 13.74% |
| Mar 31, 2019 | 28.46% |
| Dec 31, 2018 | -51.84% |
| Sep 30, 2018 | 2.06% |
| Jun 30, 2018 | 29.46% |
| Mar 31, 2018 | 37.17% |
| Dec 31, 2017 | 32.16% |
| Sep 30, 2017 | 26.52% |
| Sep 30, 2016 | 30.40% |
| Jun 30, 2016 | 42.15% |
| Mar 31, 2016 | 15.83% |
| Dec 31, 2015 | 28.55% |
| Sep 30, 2015 | 28.49% |
| Jun 30, 2015 | 48.70% |